Q2 26 EPS
$0.86
BEAT +4.05%
Est. $0.83
Q2 26 Revenue
$2.05B
BEAT +4.72%
Est. $1.96B
vs S&P Since Q2 26
-0.7%
TRAILING MARKET
IR +2.8% vs S&P +3.5%
Market Reaction
Did IR Beat Earnings? Q2 2026 Results
Ingersoll Rand Inc. Delivered a strong second quarter of 2026, beating Wall Street expectations on both the top and bottom lines as the company's operational framework drove broad-based momentum. The industrial manufacturer posted adjusted EPS of $0.… Read more Ingersoll Rand Inc. Delivered a strong second quarter of 2026, beating Wall Street expectations on both the top and bottom lines as the company's operational framework drove broad-based momentum. The industrial manufacturer posted adjusted EPS of $0.86, ahead of the $0.83 consensus estimate by 4.05%, while revenue of $2.05 billion beat expectations by 4.72% and climbed 8.5% year over year. The standout driver was the Precision and Science Technologies segment, which generated 7% organic order growth including low double-digit Life Sciences gains, and expanded its Adjusted EBITDA margin by 200 basis points to 31.5%. Free cash flow strengthened to $268.90 million from $210.40 million a year ago, and the company returned approximately $248.00 million to shareholders in the quarter. Looking ahead, management updated full-year 2026 guidance to revenue growth of 4.5% to 6.5% and Adjusted EPS of $3.45 to $3.57, noting it expects to finish near the high end of that earnings range, signaling continued confidence in its organic growth trajectory.
Key Takeaways
- • Ingersoll Rand Execution Excellence (IRX) operating framework driving operational performance
- • Strong organic revenue growth of 4.1% overall, with positive growth in all IT&S regions
- • P&ST organic orders up 7%, with low double-digit Life Sciences growth and mid single-digit Precision Technologies growth
- • P&ST Adjusted EBITDA margin expanded 200 basis points to 31.5%
- • Overall compressor orders up low single digits globally with healthy North America activity
- • Free cash flow margin expanded to 13.1% from 11.1% year-over-year
IR Forward Guidance & Outlook
Ingersoll Rand updated its full-year 2026 guidance: Revenue growth of 4.5% to 6.5% (organic growth of 1% to 3%, currency ~+1%, M&A ~+2.5%); Adjusted EBITDA of $2,130M to $2,190M with corporate costs of ~$170M; Adjusted EPS of $3.45 to $3.57 (expected to finish near the high end of the range) assuming ~22% adjusted tax rate, ~$230M net interest expense, and ~391.5M share count; Free Cash Flow to Adjusted Net Income conversion of ~95% with CAPEX at ~2% of sales. Revenue phasing is expected at 1H 48% / 2H 52%, and Adjusted EBITDA phasing at 1H 46% / 2H 54%.
IR YoY Financials
Q2 2026 vs Q2 2025, source: SEC Filings
IR Revenue by Segment
With YoY comparisons, source: SEC Filings
“Our second quarter results reflect strong organic growth and solid Adjusted EPS performance, driven by the strength of our portfolio and the consistent execution by our teams. Order momentum continues to build, reinforcing our confidence in delivering on our full-year commitments as we remain focused on staying agile, and driving durable, long-term growth.”
— Vicente Reynal, Q2 2026 Earnings Press Release
IR Earnings Trends
IR vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
IR EPS Trend
Earnings per share: estimate vs actual
IR Revenue Trend
Quarterly revenue: estimate vs actual
IR Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q2 26 BEAT | $0.83 | $0.86 | +4.05% | $2.05B | +4.72% |
| Q1 26 BEAT | $0.74 | $0.77 | +4.03% | $1.85B | +0.92% |
| Q4 25 BEAT FY | $0.90 | $0.96 | +6.57% | $2.09B | +2.58% |
| FY Full Year | — | $3.34 | — | $7.65B | — |
| Q3 25 MISS | $0.86 | $0.86 | -0.30% | $1.96B | +0.36% |
| Q2 25 BEAT | $0.80 | $0.80 | +0.40% | $1.89B | +2.21% |